[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:runx1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"RUNX1 Gene",10,9,[8,16,23,29,35,41,48,54,60,66],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07059975","UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML",[12],"Early Phase 1","RECRUITING","2026-08-26T02:17:22.949982Z","2026-05-05T02:43:29.190474Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06090669","Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency",[20],"Phase 1","2026-08-26T02:18:06.247899Z","2026-05-05T02:43:29.050668Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06313437","Revumenib in Combination With 7+3 + Midostaurin in AML",[20],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:28.835411Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04659616","Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia",[20],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:28.717298Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06152809","CIML NK Cells With Venetoclax for AML",[20],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:28.162326Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT04187105","BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)",[45],"Phase 2","2026-08-26T02:17:44.240289Z","2026-05-05T02:43:27.748653Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT02958462","Pre-myeloid Cancer and Bone Marrow Failure Clinic Study",[],"2026-08-26T02:16:16.995720Z","2026-05-05T02:43:27.746243Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06999954","Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform",[],"2026-08-26T02:15:49.658025Z","2026-05-13T02:55:06.606253Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT03854318","Longitudinal Studies of Patient With FPDMM",[],"2026-08-26T02:17:46.653867Z","2026-05-13T02:55:06.178028Z",{"nct_id":67,"title":68,"phases":69,"status":70,"updated_at":71,"content_modified":72},"NCT06261060","Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder",[45],"ACTIVE_NOT_RECRUITING","2026-08-03T03:33:02.530589Z","2026-05-05T02:43:28.984721Z"]